CC、CXC类趋化因子在宫颈癌中作用的研究进展
Research Progress of CC and CXC Chemokines in Cervical Cancer
摘要: 趋化因子在宫颈癌中能激活免疫检查点调节因子，并与肿瘤细胞增殖、侵袭、血管生成、化疗抵抗和免疫抑制等预后因素有关。为了更好地治疗宫颈癌并寻找新的有效的治疗靶点，对趋化因子有一个清晰的认识具有重大的现实意义。本文综述了CC、CXC两类趋化因子的起源和分类，以及作为生物标志物，在宫颈癌发生发展中的机制及潜在作用。
Abstract: Chemokines can activate immune checkpoint regulators in cervical cancer and are associated with prognostic factors, such as tumor cell proliferation, invasion, angiogenesis, chemotherapy resistance and immunosuppression. In order to better treat cervical cancer and find new effective therapeutic targets, it is of great practical significance to have a clear understanding of chemokines. This article reviews the origin and classification of CC and CXC chemokines, as well as the mechanism and po-tential role of CC and CXC chemokines as biomarkers in the occurrence and development of cervical cancer.
文章引用：杨强, 周留林, 钱丽华, 印慧琴. CC、CXC类趋化因子在宫颈癌中作用的研究进展[J]. 临床医学进展, 2022, 12(8): 7411-7417. https://doi.org/10.12677/ACM.2022.1281070

参考文献

[1] Buskwofie, A., David-West, G. and Clare, C.A. (2020) A Review of Cervical Cancer: Incidence and Disparities. Journal of the National Medical Association, 112, 229-232. [Google Scholar] [CrossRef] [PubMed]
[2] Huang, J., Luo, F., Shi, M., Luo, J., Ma, C., Li, S., et al. (2021) Construction and Validation of a Metabolic Gene-Associated Prognostic Model for Cervical Carcinoma and the Role on Tumor Microenvironment and Immunity. Aging, 13, 25072- 25088. [Google Scholar] [CrossRef] [PubMed]
[3] Garrido, F., Wild, C.M., Mittelberger, J., Dobler, F., Schneider, M., Ansorge, N., et al. (2021) The Role of Chemokines in Cervical Cancers. Medicina, 57, Article No. 1141. [Google Scholar] [CrossRef] [PubMed]
[4] Jamiyan, T., Kuroda, H., Yamaguchi, R., Abe, A. and Hayashi, M. (2020) CD68- and CD163-Positive Tumor-Associated Macrophages in Triple Negative Cancer of the Breast. Virchows Archiv, 477, 767-775. [Google Scholar] [CrossRef] [PubMed]
[5] Wangmo, D., Premsrirut, P.K., Yuan, C., Morris, W.S., Zhao, X. and Subramanian, S. (2021) ACKR4 in Tumor Cells Regulates Dendritic Cell Migration to Tumor-Draining Lymph Nodes and T-Cell Priming. Cancers, 13, Article No. 5021. [Google Scholar] [CrossRef] [PubMed]
[6] Zhang, L., Mao, Z., Lai, Y., Wan, T., Zhang, K., Zhou, B., et al. (2020) A Review of the Research Progress in T-Lymphocyte Im-munity and Cervical Cancer. Translational Cancer Research, 9, 2026-2036. [Google Scholar] [CrossRef] [PubMed]
[7] Tao, L., Liu, S., Xiong, J., Yang, H., Wu, Y. and Xu, A. (2021) IL-1β Promotes Cervical Cancer through Activating NF-κB/CCL-2. International Journal of Clinical and Experimental Pa-thology, 14, 426-433.
[8] Halle, M.K., Munk, A.C., Engesæter, B., Akbari, S., Frafjord, A., Hoivik, E.A., et al. (2021) A Gene Signature Identifying CIN3 Regression and Cervical Cancer Survival. Cancers, 13, Article No. 5737. [Google Scholar] [CrossRef] [PubMed]
[9] Karin, N. (2021) Chemokines in the Landscape of Cancer Immuno-therapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones? Cancers, 13, Article No. 6317. [Google Scholar] [CrossRef] [PubMed]
[10] Jiang, Y. and Chen, S. (2022) Functional New Transcription Factors (TFs) Associated with Cervical Cancer. Journal of Healthcare Engineering, 2022, Article ID: 8381559. [Google Scholar] [CrossRef] [PubMed]
[11] Kobari, L., Auclair, M., Piau, O., Ferrand, N., Zaoui, M., Delhommeau, F., et al. (2022) Circulating Cytokines Present in Multiple Myeloma Patients Inhibit the Osteoblastic Differentiation of Adipose Stem Cells. Leukemia, 36, 540-548. [Google Scholar] [CrossRef] [PubMed]
[12] Tuong, Z.K., Lukowski, S.W., Nguyen, Q.H., Chandra J, Zhou C, Gillinder K, et al. (2021) A Model of Impaired Langerhans Cell Maturation Associated with HPV Induced Epithelial Hyperplasia. iScience, 24, Article ID: 103326. [Google Scholar] [CrossRef] [PubMed]
[13] Sharma, P.C. and Gupta, A. (2020) MicroRNAs: Potential Bi-omarkers for Diagnosis and Prognosis of Different Cancers. Translational Cancer Research, 9, 5798-5818. [Google Scholar] [CrossRef] [PubMed]
[14] Yang, Y., Ding, R. and Wang, R. (2022) Identification of Candidate Targets and Mechanisms Involved in miRNA Regulation in Multiple Myeloma. World Journal of Surgical Oncology, 20, Article No. 23. [Google Scholar] [CrossRef] [PubMed]
[15] Kfoury, Y., Baryawno, N., Severe, N., Mei, S., Gustafsson, K., Hirz, T., et al. (2021) Human Prostate Cancer Bone Metastases Have an Actionable Immunosuppressive Microenviron-ment. Cancer Cell, 39, 1464-1478.e8. [Google Scholar] [CrossRef] [PubMed]
[16] Wang, Q., Schmoeckel, E., Kost, B.P., Kuhn, C., Vattai, A., Vils-maier, T., et al. (2019) Higher CCL22+ Cell Infiltration Is Associated with Poor Prognosis in Cervical Cancer Patients. Cancers, 11, Article No. 2004. [Google Scholar] [CrossRef] [PubMed]
[17] Pannunzio, A. and Coluccia, M. (2018) Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature. Pharmaceuticals, 11, Arti-cle No. 101. [Google Scholar] [CrossRef] [PubMed]
[18] Zhang, W., Wu, Q., Wang, C., Yang, L., Liu, P. and Ma, C. (2018) AKIP1 Promotes Angiogenesis and Tumor Growth by Upregulating CXC-Chemokines in Cervical Cancer Cells. Molec-ular and Cellular Biochemistry, 448, 311-320. [Google Scholar] [CrossRef] [PubMed]
[19] Qi, Y.L., Li, Y., Man, X.X., Sui, H.Y., Zhao, X.L., Zhang, P.X., et al. (2020) CXCL3 Overexpression Promotes the Tumorigenic Potential of Uterine Cervical Cancer Cells via the MAPK/ERK Pathway. Journal of Cellular Physiology, 235, 4756-4765. [Google Scholar] [CrossRef] [PubMed]
[20] Feng, X., Zhang, D., Li, X., Ma, S., Zhang, C., Wang, J., et al. (2018) CXCL5, the Upregulated Chemokine in Patients with Uterine Cervix Cancer, in Vivo and in Vitro Contributes to Onco-genic Potential of Hela Uterine Cervix Cancer Cells. Biomedicine & Pharmacotherapy, 107, 1496-1504. [Google Scholar] [CrossRef] [PubMed]
[21] Bai, L., Yao, N., Qiao, G., Wu, L. and Ma, X. (2020) CXCL5 Contributes to the Tumorigenicity of Cervical Cancer and Is Post-Transcriptionally Regulated by miR-577. International Journal of Clinical and Experimental Pathology, 13, 2984-2993.
[22] Shen, W., Xie, X.Y., Liu, M.R. and Wang, L.L. (2019) MicroRNA-101-5p Inhibits the Growth and Metastasis of Cervical Cancer Cell by Inhibiting CXCL6. European Review for Medical and Pharmacological Sciences, 23, 1957-1968.
[23] Gu, L., Yao, Y. and Chen, Z. (2021) An In-ter-Correlation among Chemokine (C-X-C Motif) Ligand (CXCL) 1, CXCL2 and CXCL8, and Their Diversified Poten-tial as Biomarkers for Tumor Features and Survival Profiles in Non-Small Cell Lung Cancer Patients. Translational Cancer Research, 10, 748-758. [Google Scholar] [CrossRef] [PubMed]
[24] Ding, H.M., Zhang, H., Wang, J., Zhou, J.H., Shen, F.R., Ji, R.N., et al. (2021) miR-302c-3p and miR-520a-3p Suppress the Proliferation of Cervical Carcinoma Cells by Targeting CXCL8. Molecular Medicine Reports, 23, Article No. 322. [Google Scholar] [CrossRef] [PubMed]
[25] Li, X., Zhong, Q., Luo, D., Du, Q. and Liu, W. (2019) The Prognostic Value of CXC Subfamily Ligands in Stage I-III Patients with Colo-rectal Cancer. PLOS ONE, 14, Article ID: e0214611. [Google Scholar] [CrossRef] [PubMed]
[26] Chen, X., He, H., Xiao, Y., Hasim, A., Yuan, J., Ye, M., et al. (2021) CXCL10 Produced by HPV-Positive Cervical Cancer Cells Stimulates Exosomal PDL1 Expression by Fibroblasts via CXCR3 and JAK-STAT Pathways. Frontiers in Oncology, 11, Article ID: 629350. [Google Scholar] [CrossRef] [PubMed]
[27] Fujimoto, N. and Dieterich, L.C. (2021) Mechanisms and Clinical Significance of Tumor Lymphatic Invasion. Cells, 10, Article No. 2585. [Google Scholar] [CrossRef] [PubMed]
[28] Oany, A.R., Mia, M., Pervin, T., Alyami, S.A. and Moni, M.A. (2021) Integrative Systems Biology Approaches to Identify Potential Biomarkers and Pathways of Cervical Cancer. Journal of Personalized Medicine, 11, Article No.363. [Google Scholar] [CrossRef] [PubMed]
[29] Kong, W., Zhao, G., Chen, H., Wang, W., Shang, X., Sun, Q., et al. (2021) Analysis of Therapeutic targets and Prognostic Biomarkers of CXC Chemokines in Cervical Cancer Microenvi-ronment. Cancer Cell International, 21, Article No. 399. [Google Scholar] [CrossRef] [PubMed]
[30] Ma, D., Fan, S.B., Hua, N., Li, G.H., Chang, Q. and Liu, X. (2020) Hypermethylation of Single CpG Dinucleotides at the Pro-moter of CXCL13 Gene Promoting Cell Migration in Cervical Cancer. Current Cancer Drug Targets, 20, 355-363. [Google Scholar] [CrossRef] [PubMed]

为你推荐